BRASILIA (Reuters) – Brazil health authority Anvisa said on Wednesday that trials of the COVID-19 vaccine developed by AstraZeneca and University of Oxford would continue after the death of volunteer involved in the tests.
Anvisa gave no further details on the death, citing confidentiality protocols.
(Reporting by Ricardo Brito; Editing by Christian Plumb)
